Literature DB >> 12025896

Estimating the audiogram using multiple auditory steady-state responses.

Andrew Dimitrijevic1, M Sasha John, Patricia Van Roon, David W Purcell, Julija Adamonis, Jodi Ostroff, Julian M Nedzelski, Terence W Picton.   

Abstract

Multiple auditory steady-state responses were evoked by eight tonal stimuli (four per ear), with each stimulus simultaneously modulated in both amplitude and frequency. The modulation frequencies varied from 80 to 95 Hz and the carrier frequencies were 500, 1000, 2000, and 4000 Hz. For air conduction, the differences between physiologic thresholds for these mixed-modulation (MM) stimuli and behavioral thresholds for pure tones in 31 adult subjects with a sensorineural hearing impairment and 14 adult subjects with normal hearing were 14+/-11, 5+/-9, 5+/-9, and 9+/-10 dB (correlation coefficients .85, .94, .95, and .95) for the 500-, 1000-, 2000-, and 4000-Hz carrier frequencies, respectively. Similar results were obtained in subjects with simulated conductive hearing losses. Responses to stimuli presented through a forehead bone conductor showed physiologic-behavioral threshold differences of 22+/-8, 14+/-5, 5+/-8, and 5+/-10 dB for the 500-, 1000-, 2000-, and 4000-Hz carrier frequencies, respectively. These responses were attenuated by white noise presented concurrently through the bone conductor.

Entities:  

Mesh:

Year:  2002        PMID: 12025896

Source DB:  PubMed          Journal:  J Am Acad Audiol        ISSN: 1050-0545            Impact factor:   1.664


  23 in total

1.  Determining the upper limits of stimulation for auditory steady-state response measurements.

Authors:  Michael P Gorga; Stephen T Neely; Brenda M Hoover; Darcia M Dierking; Kathryn L Beauchaine; Carol Manning
Journal:  Ear Hear       Date:  2004-06       Impact factor: 3.570

2.  [Auditory steady-state response. On the threshold of clinical usage?].

Authors:  R Mühler
Journal:  HNO       Date:  2004-09       Impact factor: 1.284

3.  Auditory steady-state responses for estimating moderate hearing loss.

Authors:  DeWet Swanepoel; Hettie Erasmus
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-09       Impact factor: 2.503

4.  [Audiometric thresholds estimated by auditory steady-state responses. Influence of EEG amplitude and test duration on accuracy].

Authors:  R Mühler; T Rahne
Journal:  HNO       Date:  2009-01       Impact factor: 1.284

5.  Frequency characteristics of contralateral sound suppression of 40-Hz auditory steady-state response.

Authors:  Hiromichi Kiyokawa; Tetsuaki Kawase; Hidetoshi Oshima; Atsuko Maki; Toshimitsu Kobayashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-09       Impact factor: 2.503

6.  Validity of correction factors applied to auditory steady-state responses (ASSRs) in normal hearing adults in chartr EP system.

Authors:  Zahra Ghasemahmad; Saeid Farahani
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-21       Impact factor: 2.503

7.  Audiometric evaluation in patients with Alzheimer's disease.

Authors:  Alexandre Villeneuve; Caroline Hommet; Charles Aussedat; Emmanuel Lescanne; Kevin Reffet; David Bakhos
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

8.  Automatic audiometry using auditory steady-state response and sequential test strategy applied to volunteers with normal hearing.

Authors:  Tiago Zanotelli; Felipe Antunes; Eduardo Mazoni Andrade Marçal Mendes; Leonardo Bonato Felix
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-06-28       Impact factor: 2.503

9.  Intra-operative monitoring of cochlear function during cochlear implantation.

Authors:  John S Oghalai; Ross Tonini; Jamie Rasmus; Claudia Emery; Spiros Manolidis; Jeffrey T Vrabec; Joann Haymond
Journal:  Cochlear Implants Int       Date:  2009-03

10.  Stimulus variability affects the amplitude of the auditory steady-state response.

Authors:  Michael I G Simpson; William P Woods; Garreth Prendergast; Sam R Johnson; Gary G R Green
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.